NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
NEW YORK, NY / ACCESS Newswire / April 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior Vice President and Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Larry Solow - CJS Securities Justin Bowers - Deutsche Bank Michael Ryskin - Bank of America David Windley - Jefferies Daniel Markowitz - Evercore ISI Thomas DeBourcy - Nephron Research Doug Schenkel - Wolfe Research Matt Etoch - Stephens Patrick Donnelly - Citi Matthew Larew - William Blair Kyle Crews - UBS Operator Good day, and thank you for standing by. Welcome to the West Pharmaceutical Services First Quarter 2025 Earnings Conference Call.
![]() WST Today Announced | Quarterly | $0.21 Per Share |
![]() WST 2 months ago Paid | Quarterly | $0.21 Per Share |
![]() WST 5 months ago Paid | Quarterly | $0.21 Per Share |
![]() WST 8 months ago Paid | Quarterly | $0.2 Per Share |
![]() WST 23 Apr 2024 Paid | Quarterly | $0.2 Per Share |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
13 Feb 2025 Date | | 1.71 Cons. EPS | 1.82 EPS |
24 Oct 2024 Date | | 1.5 Cons. EPS | 1.85 EPS |
25 Jul 2024 Date | | 1.74 Cons. EPS | 1.52 EPS |
25 Apr 2024 Date | | 1.26 Cons. EPS | 1.56 EPS |
![]() WST Today Announced | Quarterly | $0.21 Per Share |
![]() WST 2 months ago Paid | Quarterly | $0.21 Per Share |
![]() WST 5 months ago Paid | Quarterly | $0.21 Per Share |
![]() WST 8 months ago Paid | Quarterly | $0.2 Per Share |
![]() WST 23 Apr 2024 Paid | Quarterly | $0.2 Per Share |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
13 Feb 2025 Date | | 1.71 Cons. EPS | 1.82 EPS |
24 Oct 2024 Date | | 1.5 Cons. EPS | 1.85 EPS |
25 Jul 2024 Date | | 1.74 Cons. EPS | 1.52 EPS |
25 Apr 2024 Date | | 1.26 Cons. EPS | 1.56 EPS |
Medical Instruments & Supplies Industry | Healthcare Sector | Mr. Eric M. Green CEO | NYSE Exchange | US9553061055 ISIN |
US Country | 10,600 Employees | 30 Apr 2025 Last Dividend | 27 Sep 2013 Last Split | 13 Jan 1978 IPO Date |